↓ Skip to main content

Access to innovative cancer medicines in a middle-income country - the case of Mexico

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, October 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#50 of 465)
  • High Attention Score compared to outputs of the same age (86th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
1 news outlet
twitter
9 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
51 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Access to innovative cancer medicines in a middle-income country - the case of Mexico
Published in
Journal of Pharmaceutical Policy and Practice, October 2018
DOI 10.1186/s40545-018-0153-y
Pubmed ID
Authors

Daniela Moye-Holz, Rene Soria Saucedo, Jitse P van Dijk, Sijmen A Reijneveld, Hans V Hogerzeil

X Demographics

X Demographics

The data shown below were collected from the profiles of 9 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 51 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 18%
Student > Ph. D. Student 6 12%
Researcher 5 10%
Student > Bachelor 4 8%
Student > Doctoral Student 3 6%
Other 7 14%
Unknown 17 33%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 8 16%
Medicine and Dentistry 8 16%
Nursing and Health Professions 6 12%
Biochemistry, Genetics and Molecular Biology 2 4%
Economics, Econometrics and Finance 2 4%
Other 7 14%
Unknown 18 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 October 2023.
All research outputs
#2,285,078
of 24,696,958 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#50
of 465 outputs
Outputs of similar age
#47,431
of 355,501 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#3
of 9 outputs
Altmetric has tracked 24,696,958 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 465 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 355,501 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.